Gilead Sciences | GILD - Market Capitalization

Stock Price
130.40
Daily Change
-3.24 -2.42%
Monthly
-5.68%
Yearly
26.39%
Q2 Forecast
127.61

Gilead Sciences reported $163.07B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
ALKERMES USD 4.62B 333M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 166.62B 14.34B Apr/2026
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
J&J USD 561.65B 17.5B Apr/2026
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 5.26B 844M Apr/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sanofi EUR 101.43B 1.16B Apr/2026
Sarepta Therapeutics USD 2.26B 238M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025